- Home
- VALN vs CHW Comparison
VALN vs CHW Comparison
Compare VALN & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALN | CHW |
|---|---|---|
| Founded | 2012 | N/A |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.5M | 563.9M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VALN | CHW |
|---|---|---|
| Price | $4.97 | $8.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 264.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $93.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.75 | $6.98 |
| 52 Week High | $12.25 | $9.18 |
Technical Indicators
Market Signals| Indicator | VALN | CHW |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 35.46 |
| Support Level | $4.75 | $7.90 |
| Resistance Level | $5.52 | $8.27 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 46.32 | 24.66 |
Price Performance
Historical ComparisonAbout VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities, and alternative investments.